Belgium· BE-AMP-SAM487813-00
Eptifibatide Accord 0.75 mg/ml
A eptifibatide product containing eptifibatide, registered in Belgium by Accord Healthcare. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Eptifibatide is registered in 15 of 19 countries.
Countries holding a registration under ATC B01AC16 (eptifibatide), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Eptifibatide · ATC B01AC16
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Eptifibatide
- Manufacturer
- Accord Healthcare
- Country
- Belgium (BE)
- ATC code
- B01AC16
- ATC class
- Eptifibatide
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7715477
- be_apb3444593
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for eptifibatide.
Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eptifibatide · interactions on record
203 records
- 62 severe
- 76 moderate
- 65 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eptifibatide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StateseptifibatideSagent Pharmaceuticals
- FinlandEptifibatide AccordAccord Healthcare S.L.U.
- PolandEptifibatide AccordAccord Healthcare S.L.U.
- SwedenEptifibatide Accord 0,75 mg/ml Infusionsvätska, lösningAccord Healthcare S.L.U.
- IrelandEptifibatide Accord 0.75 mg/ml solution for infusionAccord Healthcare S.L.U.
- SpainEPTIFIBATIDA ACCORD 0,75 MG/ML SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- IcelandEptifibatide AccordAccord Healthcare S.L.U.
- CzechiaEPTIFIBATIDE ACCORDAccord Healthcare S.L.U., Barcelona
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Bulgaria · Ептифибатид Ромфарм
- Germany · Eptifibatid, Eptifibatid Altamedics
- Denmark · Eptifibatide "ctruz"
- Finland · Eptifibatide Ctruz
- United Kingdom (Northern Ireland) · Eptifibatide Kensington Pharma
- Hungary · Eptifibatide Rompharm
- Ireland · Eptifibatide Jed
- Iceland · Eptifibatide Accord
- Italy · Eptifibatide Alida
- Liechtenstein · Eptifibatide Accord
- Netherlands · Eptifibatide Aftpharm
- Norway · Eptifibatide Accord, Eptifibatide Ctruz
- Romania · Eptifibatidă Rompharm
- Sweden · Eptifibatide Ctruz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/21e00381-bf24-4bea-8718-f98b0c2cb9d9 GET /v1/drugs/21e00381-bf24-4bea-8718-f98b0c2cb9d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Eptifibatide Accord 0.75 mg/ml",
"name_fr": "Eptifibatide Accord 0.75 mg/ml",
"name_nl": "Eptifibatide Accord 0.75 mg/ml",
"amp_code": "SAM487813-00",
"strengths": [
"0.7500",
"1.7200"
],
"pack_count": 1,
"substances": [
"Eptifibatide",
"Sodium"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Eptifibatide",
"authorisation_numbers": [
"EU/1/15/1065/001"
]
}See everything about eptifibatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.